Cargando…

Safety and efficacy of a genetic vaccine targeting Telomerase plus chemotherapy for the therapy of canine B-cell lymphoma

Detalles Bibliográficos
Autores principales:	Gavazza, Alessandra, Lubas, George, Fridman, Arthur, Peruzzi, Daniela, Impellizeri, Joseph A, Luberto, Laura, Marra, Emanuele, Roscilli, Giuseppe, Ciliberto, Gennaro, Aurisicchio, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991223/ http://dx.doi.org/10.1186/2051-1426-1-S1-P212

Ejemplares similares

Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma
por: Impellizeri, Joseph A., et al.
Publicado: (2018)

The promise of anti-ErbB3 monoclonals as new cancer therapeutics
por: Aurisicchio, Luigi, et al.
Publicado: (2012)

Are Genetic Vaccines the Right Weapon against COVID-19?
por: Conforti, Antonella, et al.
Publicado: (2020)

SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
por: Salvatori, Giovanni, et al.
Publicado: (2020)

Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer
por: Noto, Alessia, et al.
Publicado: (2013)

Hematological, Biochemical, and Serological Findings in Healthy Canine Blood Donors after the Administration of CaniLeish® Vaccine
por: Starita, Chiara, et al.
Publicado: (2016)

A novel minigene scaffold for therapeutic cancer vaccines
por: Aurisicchio, Luigi, et al.
Publicado: (2014)

Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression
por: Ciardiello, Chiara, et al.
Publicado: (2016)

ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors
por: Fattore, Luigi, et al.
Publicado: (2015)

Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study
por: Aurisicchio, Luigi, et al.
Publicado: (2020)

An efficient T-cell epitope discovery strategy using in silico prediction and the iTopia assay platform
por: Fridman, Arthur, et al.
Publicado: (2012)

Emerging Cancer Vaccines: The Promise of Genetic Vectors
por: Aurisicchio, Luigi, et al.
Publicado: (2011)

Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients
por: Roscilli, Giuseppe, et al.
Publicado: (2014)

Retrospective and Prospective Investigations about “Quatrefoil” Erythrocytes in Canine Blood Smears
por: Gavazza, Alessandra, et al.
Publicado: (2014)

Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer
por: Vesci, Loredana, et al.
Publicado: (2015)

The perfect personalized cancer therapy: cancer vaccines against neoantigens
por: Aurisicchio, Luigi, et al.
Publicado: (2018)

Genetic Vaccination as a Flexible Tool to Overcome the Immunological Complexity of Invasive Fungal Infections
por: Luberto, Laura, et al.
Publicado: (2021)

Comparative expression pathway analysis of human and canine mammary tumors
por: Uva, Paolo, et al.
Publicado: (2009)

Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma
por: Fattore, Luigi, et al.
Publicado: (2015)

Prevalence of Dog Erythrocyte Antigen 1 in 7,414 Dogs in Italy
por: Medina Valentin, Anyela Andrea, et al.
Publicado: (2017)

Activation of the ErbB3-AKT axis promotes melanoma cell survival and proliferation in response to RAF/MEK inhibition
por: Fattore, Luigi, et al.
Publicado: (2014)

Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies
por: Fattore, Luigi, et al.
Publicado: (2013)

Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth
por: Aurisicchio, Luigi, et al.
Publicado: (2019)

A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines
por: Peruzzi, Daniela, et al.
Publicado: (2009)

Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors
por: Diaz, Claudia Marcela, et al.
Publicado: (2013)

Fluorescence Biomodulation for Canine Interdigital Furunculosis: Updates for Once-Weekly Schedule
por: Marchegiani, Andrea, et al.
Publicado: (2022)

Spheres Derived from Lung Adenocarcinoma Pleural Effusions: Molecular Characterization and Tumor Engraftment
por: Mancini, Rita, et al.
Publicado: (2011)

Neoantigen cancer vaccine augments anti-CTLA-4 efficacy
por: Salvatori, Erika, et al.
Publicado: (2022)

A DNA telomerase vaccine for canine cancer immunotherapy
por: Thalmensi, Jessie, et al.
Publicado: (2019)

Retrospective study of 613 canine cytologically normal bone marrows associated to altered hemograms: description, possible interpretation, and review of the principal physiological hematopoietic mechanisms
por: Turinelli, Vanessa, et al.
Publicado: (2023)

A linear DNA encoding the SARS-CoV-2 receptor binding domain elicits potent immune response and neutralizing antibodies in domestic cats
por: Conforti, Antonella, et al.
Publicado: (2023)

The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses?
por: Di Mambro, Tomas, et al.
Publicado: (2019)

Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants
por: Massacci, Alice, et al.
Publicado: (2020)

Trastuzumab and docetaxel in a preclinical organotypic breast cancer model using tissue slices from mammary fat pad: Translational relevance
por: VESCI, LOREDANA, et al.
Publicado: (2015)

Canine Traditional Laboratory Tests and Cardiac Biomarkers
por: Gavazza, Alessandra, et al.
Publicado: (2020)

Prevalence of Dal blood type and dog erythrocyte antigens (DEA) 1, 4, and 7 in canine blood donors in Italy and Spain
por: Proverbio, Daniela, et al.
Publicado: (2020)

Review of Canine Lymphoma Treated with Chemotherapy—Outcomes and Prognostic Factors
por: Bennett, Peter, et al.
Publicado: (2023)

Obinutuzumab Plus Chemotherapy Compared with Rituximab Plus Chemotherapy in Previously Untreated Italian Patients with Advanced Follicular Lymphoma at Intermediate–High Risk: A Cost-Effectiveness Analysis
por: Bellone, Marco, et al.
Publicado: (2021)

Impact of Nutritional Supplementation on Canine Dermatological Disorders
por: Marchegiani, Andrea, et al.
Publicado: (2020)

The natural compound fucoidan from New Zealand Undaria pinnatifida synergizes with the ERBB inhibitor lapatinib enhancing melanoma growth inhibition
por: Thakur, Varsha, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_68tv7lc9vr3vvljfu9orqa7ca6